Herd Immunity: A Success or a Failure

Sayantan Talapatra, Soaham Roy, S. Chakraborty, Nazeef Ahmed, Ayan Basu, Arindit Guha Sinha
{"title":"Herd Immunity: A Success or a Failure","authors":"Sayantan Talapatra, Soaham Roy, S. Chakraborty, Nazeef Ahmed, Ayan Basu, Arindit Guha Sinha","doi":"10.15864/ijcaes.2105","DOIUrl":null,"url":null,"abstract":"Amidst the COVID-19 pandemic, the most debated scientific topic has been Herd Immunity. It may be defined as a situation in which a major portion of a population (about 60 - 90%) develops some form of the disease and, therefore, becomes resistant to it. However, with such large number\n of cases, the healthcare facilities are bound to get overloaded. Some patients with severe cases of COVID-19 will be required to get admitted into the ICU (intensive care units) – which have limited beds. This could lead to more preventable deaths. Herd immunity has both positive and\n negative aspects. For instance, if we fail in the halfway for example in the country Sweden, then it will result in more deaths rather than decreasing the spread of infection. According to several theoretical modelling that people have conducted across the world and also in India suggest that\n there could be few waves of COVID-19 and people need to be prepared for them. In this review we are trying to assess whether herd immunity is a success or a failure.","PeriodicalId":179049,"journal":{"name":"International Journal of Chemical and Environmental Sciences","volume":"42 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Chemical and Environmental Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15864/ijcaes.2105","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Amidst the COVID-19 pandemic, the most debated scientific topic has been Herd Immunity. It may be defined as a situation in which a major portion of a population (about 60 - 90%) develops some form of the disease and, therefore, becomes resistant to it. However, with such large number of cases, the healthcare facilities are bound to get overloaded. Some patients with severe cases of COVID-19 will be required to get admitted into the ICU (intensive care units) – which have limited beds. This could lead to more preventable deaths. Herd immunity has both positive and negative aspects. For instance, if we fail in the halfway for example in the country Sweden, then it will result in more deaths rather than decreasing the spread of infection. According to several theoretical modelling that people have conducted across the world and also in India suggest that there could be few waves of COVID-19 and people need to be prepared for them. In this review we are trying to assess whether herd immunity is a success or a failure.
群体免疫:成功还是失败
在2019冠状病毒病大流行期间,最受争议的科学话题是群体免疫。它可以被定义为一种情况,即人口的大部分(约60 - 90%)发展出某种形式的疾病,并因此产生抗药性。然而,如此大量的病例,医疗机构势必会超负荷。一些患有COVID-19重症病例的患者将被要求入住床位有限的ICU(重症监护病房)。这可能导致更多可预防的死亡。群体免疫既有积极的一面,也有消极的一面。例如,如果我们在中途失败,例如在瑞典,那么它将导致更多的死亡,而不是减少感染的传播。根据人们在世界各地和印度进行的几个理论模型表明,COVID-19可能会出现几波,人们需要为此做好准备。在这篇综述中,我们试图评估群体免疫是成功还是失败。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信